We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$33.6B
AUM Growth
+$255M
Cap. Flow
-$824M
Cap. Flow %
-2.45%
Top 10 Hldgs %
29.14%
Holding
1,152
New
97
Increased
418
Reduced
387
Closed
96

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$94.4M
2
ELV icon
Elevance Health
ELV
+$74.7M
3
PAYO icon
Payoneer
PAYO
+$71.5M
4
ABT icon
Abbott
ABT
+$64.2M
5
GE icon
GE Aerospace
GE
+$63.5M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$101M
2
AAPL icon
Apple
AAPL
+$98.8M
3
AMGN icon
Amgen
AMGN
+$85.8M
4
TXN icon
Texas Instruments
TXN
+$80.9M
5
BIIB icon
Biogen
BIIB
+$73M

Sector Composition

Rank Sector Weight
1 Technology 37.8%
2 Healthcare 15.65%
3 Consumer Discretionary 11.06%
4 Financials 8.19%
5 Industrials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEHC icon
576
GE HealthCare
GEHC
$28.9B
$3.9M 0.01%
50,079
+2,303
+5% +$188K
HOOD icon
577
Robinhood
HOOD
$99.3B
$3.89M 0.01%
+171,118
New +$3.35M
INDV icon
578
Indivior Pharmaceuticals
INDV
$4.04B
$3.88M 0.01%
240,978
-37,254
-13% -$672K
MAS icon
579
Masco
MAS
$13.6B
$3.88M 0.01%
58,188
+24,506
+73% +$1.73M
MLM icon
580
Martin Marietta Materials
MLM
$36B
$3.87M 0.01%
7,141
-1,069
-13% -$621K
QLYS icon
581
Qualys
QLYS
$6.41B
$3.86M 0.01%
27,036
-52,945
-66% -$8.06M
BILL icon
582
BILL Holdings
BILL
$4.26B
$3.82M 0.01%
72,644
+34,491
+90% +$1.95M
MPWR icon
583
Monolithic Power Systems
MPWR
$56.1B
$3.82M 0.01%
4,647
-1,389
-23% -$1M
REXR icon
584
Rexford Industrial Realty
REXR
$8.61B
$3.78M 0.01%
84,826
VRT icon
585
Vertiv
VRT
$90.3B
$3.77M 0.01%
43,581
-17,837
-29% -$1.62M
RF icon
586
Regions Financial
RF
$25.3B
$3.76M 0.01%
187,749
+103,295
+122% +$2M
WTS icon
587
Watts Water Technologies
WTS
$11.7B
$3.75M 0.01%
20,461
BKR icon
588
Baker Hughes
BKR
$56.3B
$3.74M 0.01%
106,245
+7,394
+7% +$243K
PLRX icon
589
Pliant Therapeutics
PLRX
$69.4M
$3.73M 0.01%
347,389
+195
+0.1% +$2.51K
EMR icon
590
Emerson Electric
EMR
$82B
$3.7M 0.01%
33,582
+22
+0.1% +$2.43K
ULTA icon
591
Ulta Beauty
ULTA
$23.3B
$3.69M 0.01%
9,565
-26,328
-73% -$10.7M
VAC icon
592
Marriott Vacations Worldwide
VAC
$3.48B
$3.68M 0.01%
42,100
TNET icon
593
TriNet
TNET
$3.18B
$3.67M 0.01%
36,743
-27,052
-42% -$3.01M
WTW icon
594
Willis Towers Watson
WTW
$29.9B
$3.67M 0.01%
13,996
+1,334
+11% +$344K
COP icon
595
ConocoPhillips
COP
$170B
$3.67M 0.01%
32,046
+2,116
+7% +$257K
DVA icon
596
DaVita
DVA
$12.2B
$3.64M 0.01%
26,268
+10,521
+67% +$1.45M
YUM icon
597
Yum! Brands
YUM
$38.4B
$3.61M 0.01%
27,287
-527
-2% -$72.5K
USB icon
598
US Bancorp
USB
$96.9B
$3.61M 0.01%
90,862
+40,147
+79% +$1.64M
IRTC icon
599
iRhythm Holdings
IRTC
$3.69B
$3.55M 0.01%
32,987
RCUS icon
600
Arcus Biosciences
RCUS
$3.1B
$3.54M 0.01%
232,200
+128
+0.1% +$2.07K

Similar funds

Axa's Q2 2024 Portfolio in Review

As of Q2 2024, Axa held 1,152 positions worth $33.6B, up 0.76% from $33.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Axa's Q2 2024 filing shows 97 new, 418 increased, 387 reduced and 96 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M. The largest sale was UnitedHealth, an estimated $101M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M.
  • Axa added most to Advanced Micro Devices in Q2 2024, an estimated $94.4M increase.
  • Axa's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $101M.
  • Axa fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $46.4M.
  • Axa's ten largest holdings make up 29% of its $33.6B portfolio in Q2 2024.
  • Axa opened 97 new positions and closed 96 in Q2 2024.
  • Axa's portfolio value rose 0.76% quarter-over-quarter to $33.6B.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.